Similar articles

• [On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].

  Heer S, Femmer K. Heer S, et al. Pharmazie. 1980;34(5-6):317-20. Pharmazie. 1980. PMID: 6106208 German. No abstract available.
• Pharmacology of a new beta-adrenoceptor blocking agent, The 15219.

  Caputi AP, Marmo E, Saini RK. Caputi AP, et al. Res Commun Chem Pathol Pharmacol. 1972 Jul;4(1):25-35. Res Commun Chem Pathol Pharmacol. 1972. PMID: 4152996 No abstract available.
• [Hemodynamic action of talinolol (Cordanum, 02-115), a new beta-receptor blocking substance, in man].

  Wolf P, Feller K, Femmer K. Wolf P, et al. Pharmazie. 1975 Oct;30(10):678-81. Pharmazie. 1975. PMID: 696 German. No abstract available.
• Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 9. Nadolol: a new long-acting beta-adrenoceptor blocking drug.

  Frishman W. Frishman W. Am Heart J. 1980 Jan;99(1):124-8. doi: 10.1016/0002-8703(80)90322-1. Am Heart J. 1980. PMID: 6101295 Review. No abstract available.
• Basic pharmacology of esmolol.

  Gorczynski RJ. Gorczynski RJ. Am J Cardiol. 1985 Oct 23;56(11):3F-13F. doi: 10.1016/0002-9149(85)90910-5. Am J Cardiol. 1985. PMID: 2864846 Review.